News

CEP Revision extends HAPILA Estriol API retest period to 60 months

[Translate to Englisch:] Molekularstruktur von Estriol

23 June 2022 High-potency active ingredient specialist CDMO HAPILA GmbH (HAPILA) has welcomed a further revision of the Certification of suitability of Monographs of the European Pharmacopoeia (CEP) for Estriol that extends the minimum shelf life of


 


Authorities confirm cGMP status for HAPILA’s Estriol estrogen API manufacturing

[Translate to Englisch:] Molekularstruktur von Estriol

17.02.22 High-potency active ingredient specialist HAPILA GmbH (HAPILA) has received regulatory confirmation that its manufacturing facility for innovative estrogen agonist API Estriol complies with Good Manufacturing Practice (cGMP) standards. Re


 


Welcome to HAPILA

Founded in 2007 by scientists and technicians of long-standing experience in the pharmaceutical industry, HAPILA GmbH provides high-value services to a broad range of customers covering medium-sized pharmaceutical companies, “Big Pharma”, Generics, R&D, Biotech and Fine Chemicals. We offer the highest levels of expertise to solve demanding problems in the development and manufacture of pharmaceutical ingredients.

HAPILAHighly Active Pharmaceutical Ingredient LAbs

With our highly motivated and expert team, we offer our customers early stage development up to and including GMP manufacturing in the fields of synthesis, purification and design.

Learn more:

  • HAPILA is located in Gera/Germany at the outskirts of an industrial estate with easy access: the A4 autobahn and local aerodrome are nearby, and Halle-Leipzig, Dresden and Erfurt Airports are each just one hour away
  • There are neighbouring high-tech centres in Jena, Halle-Leipzig, and Dresden providing excellent opportunities for scientific networking
  • With flexible financing, HAPILA is independent and thus free in its decision-making - an advantage regarding projectselection and any short-term investments needed for their progression
  • We aim to develop the company on an on-going basis through sound and organic growth – with our employees taking part in and profiting long-term from this goal
  • We are dedicated to being a long-term, reliable and exceptional partner that provides real solutions and value to our clients in the pharmaceutical, biotechnology and chemical industries